Works matching IS 13075888 AND DT 2021
Results: 74
Brucellosis as a rare cause of granulomatous hepatitis with hepatic and bone marrow granulomas: A case report.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 137, doi. 10.14744/hf.2021.2021.0038
- By:
- Publication type:
- Article
The relationship between polyphenols and miRNAs: A novel therapeutic strategy for metabolic associated fatty liver disease.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 128, doi. 10.14744/hf.2021.2021.0037
- By:
- Publication type:
- Article
Sustainability of diet-based moderate calorie restriction among obese patients with metabolic-associated fatty liver disease.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 97, doi. 10.14744/hf.2021.2021.0014
- By:
- Publication type:
- Article
An overview of SARS-COV-2-related hepatic injury.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 122, doi. 10.14744/hf.2021.2021.0020
- By:
- Publication type:
- Article
Immunoglobulin light chain amyloidosis presenting as Budd-Chiari syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
De novo hepatitis B surface antigen (HBsAg)-positive, core antibody (anti-HBc)-negative, hepatitis B virus infection post-liver transplant from an anti-HBc, HBsAg-negative donor.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 117, doi. 10.14744/hf.2021.2021.0019
- By:
- Publication type:
- Article
A novel insight into the pathophysiology of autoimmune hepatitis: An immune activator mutation in the FLT3 receptor.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 112, doi. 10.14744/hf.2021.2021.0010
- By:
- Publication type:
- Article
An appointment lead time of more than two weeks is significantly associated with not presenting for a liver biopsy procedure.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 107, doi. 10.14744/hf.2021.2021.0032
- By:
- Publication type:
- Article
The effect of transarterial chemoembolization therapy on survival in patients with non-resectable hepatocellular carcinoma: Single-center study results.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 102, doi. 10.14744/hf.2021.2021.0029
- By:
- Publication type:
- Article
Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection?
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 91, doi. 10.14744/hf.2021.2021.0027
- By:
- Publication type:
- Article
New therapeutic players on the horizon: Edible plant derived exosomes.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Splenomegaly and hypersplenism in hepatic vena cava syndrome.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 2, p. 69, doi. 10.14744/hf.2021.2021.0008
- By:
- Publication type:
- Article
Frailty in liver transplantation: A comprehensive review.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 2, p. 80, doi. 10.14744/hf.2021.2021.0023
- By:
- Publication type:
- Article
In the presence of autoantibodies and iron overload, do not judge a book by its cover: A case report.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 2, p. 76, doi. 10.14744/hf.2021.2021.0013
- By:
- Publication type:
- Article
Artificial intelligence method to predict overall survival of hepatocellular carcinoma.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 2, p. 64, doi. 10.14744/hf.2021.2021.0017
- By:
- Publication type:
- Article
Causes of erectile dysfunction in non-alcoholic fatty liver disease.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 2, p. 60, doi. 10.14744/hf.2021.2021.0012
- By:
- Publication type:
- Article
Artificial intelligence to predict overall survivals of patients with cirrhosis and outcomes of variceal bleeding.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 2, p. 55, doi. 10.14744/hf.2021.2021.0016
- By:
- Publication type:
- Article
Prognostic factors, treatment methods and survival time in hepatocellular carcinoma: A decade of experience at a single center.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 2, p. 49, doi. 10.14744/hf.2021.2021.0001
- By:
- Publication type:
- Article
Significance of detectable hepatitis B virus DNA in liver allograft tissue in long-term follow-up of liver transplant recipients.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 2, p. 43, doi. 10.14744/hf.2021.2021.0003
- By:
- Publication type:
- Article
The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 2, p. 37, doi. 10.14744/hf.2021.2020.0033
- By:
- Publication type:
- Article
Evaluation of primary immunodeficiency in patients with autoimmune liver diseases.
- Published in:
- Hepatology Forum, 2021, p. 24
- By:
- Publication type:
- Article
The analysis of liver transplant patients with COVID-19 infection: A national cohort.
- Published in:
- Hepatology Forum, 2021, p. 24
- By:
- Publication type:
- Article
Etiologic, demographic and clinical characteristics of patients with hepatocellular carcinoma in Turkey: A multicenter study.
- Published in:
- Hepatology Forum, 2021, p. 23
- By:
- Publication type:
- Article
Non-alcoholic fatty liver disease and extrahepatic malignancy.
- Published in:
- Hepatology Forum, 2021, p. 22
- By:
- Publication type:
- Article
Tenofovir alafenamide in HBV: Real life data from Turkey.
- Published in:
- Hepatology Forum, 2021, p. 22
- By:
- Publication type:
- Article
Efficacy and safety of tenofovir alafenamide in chronic hepatitis B patients with chronic hemodialysis and kidney transplantation.
- Published in:
- Hepatology Forum, 2021, p. 19
- By:
- Publication type:
- Article
Comparison of liver histopathology with non-invasive inflammation markers as neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume (MPV) in chronic hepatitis B patients.
- Published in:
- Hepatology Forum, 2021, p. 21
- By:
- Publication type:
- Article
Effect of Tenofovir Alafenamide Fumarate (TAF) prophylaxis for hepatitis B virus reactivation in HBV-infected individuals, who received chemo/immunosuppressive therapy.
- Published in:
- Hepatology Forum, 2021, p. 20
- By:
- Publication type:
- Article
Relationship of histological grading of hepatocellular carcinoma with morphological factors and AFP levels.
- Published in:
- Hepatology Forum, 2021, p. 20
- By:
- Publication type:
- Article
Changes in transaminase and bilirubin values of COVID-19 infected patients who were followed up and died in the intensive care unit.
- Published in:
- Hepatology Forum, 2021, p. 19
- By:
- Publication type:
- Article
Evaluation of non-invazive markers (APRI, KING SKOR, GUCI, FIB4, AAR, AP) to show fibrosis in patients with chronic hepatitis B.
- Published in:
- Hepatology Forum, 2021, p. 21
- By:
- Publication type:
- Article
Real-life efficacy and tolerability of tenofovir alafenamide fumarate (TAF) in special groups of Hepatitis B patients: Liver transplant recipients and cirrhosis.
- Published in:
- Hepatology Forum, 2021, p. 18
- By:
- Publication type:
- Article
Etiology and clinical characteristics of cirrhosis by underlying cause.
- Published in:
- Hepatology Forum, 2021, p. 17
- By:
- Publication type:
- Article
Does nonalcoholic pancreatosteatosis always correlate with nonalcoholic fatty liver?
- Published in:
- Hepatology Forum, 2021, p. 16
- By:
- Publication type:
- Article
Evaluation of the effectiveness of the HCView computer alarm program in the management of patients undergoing anti-HCV testing.
- Published in:
- Hepatology Forum, 2021, p. 16
- By:
- Publication type:
- Article
Changes in lipid profile among HBV patients treated with tenofovir alafenamide: Turkey's experience of real life setting.
- Published in:
- Hepatology Forum, 2021, p. 15
- By:
- Publication type:
- Article
Can FIB-4 score combined with MR elastography predict NASH-related fibrosis?
- Published in:
- Hepatology Forum, 2021, p. 15
- By:
- Publication type:
- Article
Comparison of two different transient elastography methods for assessment of liver fibrosis.
- Published in:
- Hepatology Forum, 2021, p. 14
- By:
- Publication type:
- Article
An analysis of the liver enzyme levels in pediatric patients with COVID-19: A single center results.
- Published in:
- Hepatology Forum, 2021, p. 14
- By:
- Publication type:
- Article
Role of hepatosteatosis in HBsAg seroconversion in HBeAg-negative chronic hepatitis B patients.
- Published in:
- Hepatology Forum, 2021, p. 14
- By:
- Publication type:
- Article
Kaposi's sarcoma in autoimmune hepatitis shortly after azathioprine and corticosteroid treatment.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
The effects of NOD2 variants on the duration of hospitalization in patients with biliary strictures after liver transplantation.
- Published in:
- Hepatology Forum, 2021, p. 13
- By:
- Publication type:
- Article
Hepatic steatosis effects hepatitis B virus surface antigen seroclearance in individuals with chronic hepatitis B virus infection.
- Published in:
- Hepatology Forum, 2021, p. 12
- By:
- Publication type:
- Article
The prevalance of hepatitis-E virus infection in adult Turkish population: Systematic review of the literature and prevalence study in blood donors in mersin province.
- Published in:
- Hepatology Forum, 2021, p. 12
- By:
- Publication type:
- Article
Serum levels of ADAMTS-7 and 12 as hepatic fibrosis markers in patients with chronic hepatitis B.
- Published in:
- Hepatology Forum, 2021, p. 11
- By:
- Publication type:
- Article
Systemic sarcoidosis-associated hepatocellular carcinoma: A case report.
- Published in:
- Hepatology Forum, 2021, p. 11
- By:
- Publication type:
- Article
Hepatitis E virus IgG seroprevalence in liver transplant patients: A retrospective single-center experience.
- Published in:
- Hepatology Forum, 2021, p. 10, doi. 10.14744/hf.2020.2020.0030
- By:
- Publication type:
- Article
The effect of sarcopenia in liver transplantation.
- Published in:
- Hepatology Forum, 2021, p. 10
- By:
- Publication type:
- Article
Evaluation of prothrombin index in chronic hepatitis B patients.
- Published in:
- Hepatology Forum, 2021, p. 9
- By:
- Publication type:
- Article
Diagnostic validity of non-invasive tests for predicting liver fibrosis stage in chronic hepatitis B patients with HBV DNA>2000 IU/mL, ALT>ULN.
- Published in:
- Hepatology Forum, 2021, p. 9
- By:
- Publication type:
- Article